Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) - a Pilot Study

NCT07133659 is registered in ClinicalTrials.gov with Al-Mustansiriyah University as lead sponsor.

NCT NCT07133659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07133659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) - a Pilot Study
Lead sponsor
Al-Mustansiriyah University
Phase
Phase 4
Overall status
Recruiting
Start date
June 8, 2025
Completion date
July 8, 2027
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

itp - immune thrombocytopenia